Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Study Finds Data Scarce Where US FDA Wants To Gauge Hemp Safety – Reproductive Toxicity

Nov 06 2022

• By Bob Kronemyer

• Source: Shutterstock

Related Content

Safety Concerns Are US FDA's Answer To Question On Regulatory Pathway For Hemp’s Lawful Use

Jun 15 2022

‘Rope Not Dope’ Still Convince Congress On Hemp?

Nov 06 2022

US Lawful Use Of Hemp In Supplements Could Strike Out Despite Scoring In Marketplace

Nov 06 2022

Funding For US FDA Work On Cannabinoids Regulatory Pathway Drives Progress Only So Far

Apr 08 2021

Additional Topics

International United States Cannabidiol CBD FDA Regulation Commercial Consumer Dietary Supplements Ingredients Legislation Manufacturing Policy Politics Research & Development Retail Supply Chain

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window